Preclinical Evaluation of hnRNPA2B1 Antibody in Human Triple-Negative Breast Cancer MDA-MB-231 Cells via PET Imaging

Triple-negative breast cancer (TNBC) does not express estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. Because TNBC lacks the expression of commonly targeted receptors, it is challenging to develop a new imaging agent for this cancer subtype. Heterogeneous nucl...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Abhinav Bhise, Hyun Park, Woonghee Lee, Swarbhanu Sarkar, Yeong Su Ha, Subramani Rajkumar, Bora Nam, Jeong Eun Lim, Phuong Tu Huynh, Kiwoong Lee, Ji-Yoon Son, Jung Young Kim, Kyo Chul Lee, Jeongsoo Yoo
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2022-08-01
Серія:	Pharmaceutics
Предмети:	hnRNPA2B1 immuno-PET pretargeting triple-negative breast cancer nuclear imaging
Онлайн доступ:	https://www.mdpi.com/1999-4923/14/8/1677
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Preclinical Evaluation of hnRNPA2B1 Antibody in Human Triple-Negative Breast Cancer MDA-MB-231 Cells via PET Imaging

Схожі ресурси